The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation

C Ponticelli, MR Campise - Kidney International, 2021 - Elsevier
Several factors, such as donor brain death, ischemia-reperfusion injury, rejection, infection,
and chronic allograft dysfunction, may induce an inflammatory state in kidney …

Treatment of dyslipidemia in kidney transplantation

C Ponticelli, L Arnaboldi, G Moroni… - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction: Lipid disorders are frequent after kidney transplantation (KT) and KT recipients
are considered at high-or very-high cardiovascular risk. Among many concurring factors, a …

Statin initiation and risk of incident kidney disease in patients with diabetes

S Zhou, L Su, R Xu, Y Li, R Chen, Y Cao, P Gao… - Cmaj, 2023 - Can Med Assoc
Background: The role of statin therapy in the development of kidney disease in patients with
type 2 diabetes mellitus (DM) remains uncertain. We aimed to determine the relationships …

Nephrologisches management und medikamentendosierung Bei rheumapatienten mit niereninsuffizienz

SM Weiner - Zeitschrift für Rheumatologie, 2022 - Springer
Zusammenfassung Hintergrund Bei Patienten mit entzündlich rheumatischen Erkrankungen
und Niereninsuffizienz ergeben sich für den Therapeuten zwei Herausforderungen: die …

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

DJ Tunnicliffe, SC Palmer… - Cochrane Database …, 2023 - cochranelibrary.com
Background Cardiovascular disease is the most frequent cause of death in people with early
stages of chronic kidney disease (CKD), and the absolute risk of cardiovascular events is …

Nephrologisches Management und Medikamentendosierung bei Rheumapatienten mit Niereninsuffizienz–Teil 2

SM Weiner - Rheuma Plus/Schweiz, 2024 - Springer
Zusammenfassung Hintergrund Bei Patienten mit entzündlich rheumatischen Erkrankungen
und Niereninsuffizienz ergeben sich für den Therapeuten zwei Herausforderungen: die …

Sztatinkezelés vesebetegekben: mit, mennyit, mikor?

S Károly - Hypertonia és Nephrologia, 2023 - search.ebscohost.com
The association between an elevated cholesterol value and the risk of cardiovascular
disease is well known. Over decades various classes of drugs were introduced to decrease …

Variabilité de la réponse pharmacologique, modélisation et influence des plans expérimentaux

C Couffignal - 2021 - theses.hal.science
Le nombre croissant de patients ayant une maladie chronique, pour la plupart assujettis à la
prise d'un traitement au long terme, justifie l'exploration et la caractérisation des facteurs …

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin

MYAM Kroonen, J Stevens, D de Zeeuw… - Diabetes, Obesity …, 2019 - Wiley Online Library
Aim The PLANET trials showed that atorvastatin 80 mg but not rosuvastatin at either 10 or 40
mg reduced urinary protein to creatinine ratio (UPCR) at similar effects on LDL‐cholesterol …

[PDF][PDF] Estatinas, drogas de amplio espectro de acción y beneficios

I Arocha-Rodulfo - Revista Hospital Clínico Universidad de Chile, 2019 - redclinica.cl
Sin lugar a dudas, existe una estrecha relación entre las cifras elevadas del colesterol unido
a las lipoproteínas de baja densidad (C-LDL) con un mayor riesgo de aterosclerosis y sus …